1,021
Views
45
CrossRef citations to date
0
Altmetric
Review

Socioeconomic status and health outcomes: cystic fibrosis as a model

&
Pages 967-977 | Received 28 Mar 2016, Accepted 27 May 2016, Published online: 09 Jun 2016

References

  • Davis PB, Drumm M, Konstan MW. Cystic fibrosis – state of the art. Am J Respir Crit Care Med. 1996;154:1229–1256.
  • Marshall BC, Samuelson WM. Basic therapies in cystic fibrosis. Does standard therapy work? Clin Chest Med. 1998;19(3):487–504, vi.
  • Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis. Correlation between genotype and phenotype in patients with cystic fibrosis. The cystic fibrosis genotype-phenotype consortium. N Engl J Med. 1993;329(18):1308–1313.
  • Collaco JM, Blackman SM, McGready J, et al. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010;157(5):802–803.
  • Wolfenden LL, Schechter MS. Genetic and non-genetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev. 2009;10(1):32–36.
  • Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci. 2010;1214:57–69.
  • Mogayzel PJ Jr., Dunitz J, Marrow LC, et al. Improving chronic care delivery and outcomes: the impact of the cystic fibrosis care center network. BMJ Qual Saf. 2014;23(Suppl 1):i3–8.
  • Schechter MS, Fink AK, Homa K, et al. The cystic fibrosis foundation patient registry as a tool for use in quality improvement. BMJ Qual Saf. 2014;23(Suppl 1):i9–14.
  • Vanscoy LL, Blackman SM, Collaco JM, et al. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med. 2007;175(10):1036–1043.
  • Oakes JM, Rossi PH. The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med. 2003;56(4):769–784.
  • Galobardes B, Shaw M, Lawlor DA, et al. Indicators of socioeconomic position (Part 1). J Epidemiol Community Health. 2006;60(1):7–12.
  • Szaflarski M, Kudel I, Cotton S, et al. Multidimensional assessment of spirituality/religion in patients with HIV: conceptual framework and empirical refinement. J Relig Health. 2012;51(4):1239–1260.
  • Adler NE, Rehkopf DH. U.S. Disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health. 2008;29:235–252.
  • Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: one size does not fit all. JAMA. 2005;294(22):2879–2888.
  • Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health. 2010;100(Suppl 1):S186–96.
  • Adler NE, Ostrove JM. Socioeconomic status and health: what we know and what we don’t. Socioecon Status Health Ind Nations. 1999;896:3–15.
  • Braveman P, Egerter S. Overcoming obstacles to health. A Report from the Robert Wood Johnson Foundation to the Commission to Build a Healthier America. New Brunswick (NJ): Robert Wood Johnson Foundation; 2008.
  • Krieger N, Rehkopf DH, Chen JT, et al. The fall and rise of US inequities in premature mortality: 1960–2002. PLoS Med. 2008;5(2):e46.
  • Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;35:80–94.
  • Elo I. Social class differentials in health and mortality: patterns and explanations in comparative perspective. Annu Rev Sociol. 2009;35:553–572.
  • Jemal A, Thun MJ, Ward EE, et al. Mortality from leading causes by education and race in the United States, 2001. Am J Prev Med. 2008;34(1):1–8.
  • Evans G, Brooks-Gunn J, Kato Klebanov P. Stressing out the poor: chronic physiological stress and the income-achievement gap. Pathways. 2011;16–21.
  • Gregorio DI, Walsh SJ, Paturzo D. The effects of occupation-based social position on mortality in a large American cohort. Am J Public Health. 1997;87(9):1472–1475.
  • Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil-servants – the whitehall-II study. Lancet. 1991;337(8754):1387–1393.
  • Williams DR, Mohammed SA, Leavell J, et al. Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci. 2010;1186:69–101.
  • Farmer MM, Ferraro KF. Are racial disparities in health conditional on socioeconomic status? Soc Sci Med. 2005;60(1):191–204.
  • Hayward MD, Crimmins EM, Miles TP, et al. The significance of socioeconomic status in explaining the racial gap in chronic health conditions. Am Sociol Rev. 2000;65(6):910–930.
  • Williams DR, Collins C. US Socioeconomic and racial differences in health: patterns and explanations. Annu Rev Sociol. 1995;21:349–386.
  • Williams DR. Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann N Y Acad Sci. 1999;896:173–188.
  • McGinnis JM, Williams-Russo P, Knickman JR. The case for more active policy attention to health promotion. Health Aff (Millwood). 2002;21(2):78–93.
  • Stringhini S, Sabia S, Shipley M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010;303(12):1159–1166.
  • Pappas G, Queen S, Hadden W, et al. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–109.
  • Lynch JW, Kaplan GA, Salonen JT. Why do poor people behave poorly? variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse. Soc Sci Med. 1997;44(6):809–819.
  • Britton JR. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ. 1989;298(6672):483–487.
  • Barr HL, Britton J, Smyth AR, et al. Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. Br Med J. 2011;343. doi:10.1136/bmj.d4662.
  • Curtis JR, Burke W, Kassner AW, et al. Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis. Am J Respir Crit Care Med. 1997;155(6):1921–1924.
  • Schechter MS, Shelton BJ, Margolis PA, et al. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001;163(6):1331–1337.
  • O’Connor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics. 2003;111(4 Pt 1):e333–339.
  • Smith PJ, Blumenthal JA, Trulock EP, et al. Psychosocial predictors of mortality following lung transplantation. Am J Transplant. 2016;16(1):271–277.
  • Taylor-Robinson DC, Smyth RL, Diggle PJ, et al. The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study. Lancet Respir Med. 2013;1(2):121–128.
  • Kovell LC, Wang J, Ishman SL, et al. cystic fibrosis and sinusitis in children: outcomes and socioeconomic status. Otolaryngol Head Neck Surg. 2011;145(1):146–153.
  • Sanders DB, Emerson J, Ren CL, et al. Early childhood risk factors for decreased FEV1 at age six to seven years in young children with cystic fibrosis. Ann Am Thorac Soc. 2015;12(8):1170–1176.
  • Balmer DF, Schall JI, Stallings VA. Social disadvantage predicts growth outcomes in preadolescent children with cystic fibrosis. J Cyst Fibros. 2008;7(6):543–550.
  • Oates GR, Stepanikova I, Gamble S, et al. Adherence to airway clearance therapy in pediatric cystic fibrosis: socioeconomic factors and respiratory outcomes. Pediatr Pulmonol. 2015;50(12):1244–1252.
  • Gupta A, Urquhart D, Rosenthal M. Marked improvement in cystic fibrosis lung disease and nutrition following change in home environment. J R Soc Med. 2009;102(Suppl 1):45–48.
  • Schechter MS, Margolis PA. Relationship between socioeconomic status and disease severity in cystic fibrosis. J Pediatr. 1998;132(2):260–264.
  • Macpherson C, Redmond AO, Leavy A, et al. A review of cystic fibrosis children born to single mothers. Acta Paediatr. 1998;87(4):397–400.
  • Britton LJ, Mims C, Harris WT, et al. Predictors of patient outcomes at 12 months of age in patients diagnosed by newborn screening (Abstract). Pediatr Pulmonol. 2013;48(S36):372–373.
  • Barker DJ. The developmental origins of chronic adult disease. Acta Paediatr Suppl. 2004;93(446):26–33.
  • Sandman CA, Davis EP. neurobehavioral risk is associated with gestational exposure to stress hormones. Expert Rev Endocrinol Metab. 2012;7(4):445–459.
  • Lu MC, Halfon N. Racial and ethnic disparities in birth outcomes: a life-course perspective. Matern Child Health J. 2003;7(1):13–30.
  • Brunton PJ. Programming the brain and behaviour by early-life stress: a focus on neuroactive steroids. J Neuroendocrinol. 2015;27(6):468–480.
  • Zhu P, Sun MS, Hao JH, et al. Does prenatal maternal stress impair cognitive development and alter temperament characteristics in toddlers with healthy birth outcomes? Dev Med Child Neurol. 2014;56(3):283–289.
  • Sandman CA. Fetal exposure to placental corticotropin-releasing hormone (pcrh) programs developmental trajectories. Peptides. 2015;72:145–153.
  • Smith R, Nicholson RC. Corticotrophin releasing hormone and the timing of birth. Front Biosci. 2007;12:912–918.
  • Hayward MD, Gorman BK. The long arm of childhood: the influence of early-life social conditions on men’s mortality. Demography. 2004;41(1):87–107.
  • Lynch J, Smith GD, Hillemeier M, et al. Income inequality, the psychosocial environment, and health: comparisons of wealthy nations. Lancet. 2001;358(9277):194–200.
  • Thun M, Peto R, Boreham J, et al. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21(2):96–101.
  • Kim JE, Tsoh JY. Cigarette smoking among socioeconomically disadvantaged young adults in association with food insecurity and other factors. Prev Chronic Dis. 2016;13:E08.
  • Collaco JM, Vanscoy L, Bremer L, et al. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA. 2008;299(4):417–424.
  • Schechter MS. Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med. 2011;17(6):448–454.
  • Schechter MS. Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Respir Crit Care Med. 2003;24(6):639–652.
  • Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med. 1990;323(12):782–788.
  • Goss CH, Rubenfeld GD, Ramsey BW, et al. Clinical trial participants compared with nonparticipants in cystic fibrosis. Am J Respir Crit Care Med. 2006;173(1):98–104.
  • Schechter M, Emerson J, Rosenfeld M. The relationship of socioeconomic status and environmental tobacco smoke exposure with disease outcomes in the EPIC observational cohort. Pediatr Pulmonol. 2012;47:S35.
  • Wheeler BW, Ben-Shlomo Y. Environmental equity, air quality, socioeconomic status, and respiratory health: a linkage analysis of routine data from the health survey for England. J Epidemiol Community Health. 2005;59(11):948–954.
  • Hajat A, Hsia C, O’Neill MS. Socioeconomic disparities and air pollution exposure: a global review. Curr Environ Health Rep. 2015;2(4):440–450.
  • Ard K. Trends in exposure to industrial air toxins for different racial and socioeconomic groups: a spatial and temporal examination of environmental inequality in the U.S. from 1995 to 2004. Soc Sci Res. 2015;53:375–390.
  • Deguen S, Petit C, Delbarre A, et al. Neighbourhood characteristics and long-term air pollution levels modify the association between the short-term nitrogen dioxide concentrations and all-cause mortality in Paris. PLoS One. 2015;10(7):e0131463.
  • Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med. 2004;351(11):1057–1067.
  • Pope CA, Thun MJ, Namboodiri MM, et al. Particulate air-pollution as a predictor of mortality in a prospective study of US adults. Am J Respir Crit Care Med. 1995;151(3 Pt 1):669–674.
  • Goeminne PC, Kiciński M, Vermeulen F, et al. Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest. 2013;143(4):946–954.
  • Goss CH, Newsom SA, Schildcrout JS, et al. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med. 2004;169(7):816–821.
  • Psoter KJ, De Roos AJ, Mayer JD, et al. Fine particulate matter exposure and initial pseudomonas aeruginosa acquisition in cystic fibrosis. Ann Am Thorac Soc. 2015;12(3):385–391.
  • Cystic fibrosis foundation patient registry: 2013 annual data report to center directors. Bethesda, MD: Cystic Fibrosis Foundation, 2014.
  • Borowitz D. The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis. Curr Opin Pulm Med. 1996;2(6):457–461.
  • Schöni MH, Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review. Clin Nutr. 2000;19(2):79–85.
  • Steinkamp G, Wiedemann B, Grp GC. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF Quality Assurance (CFQA) project. Thorax. 2002;57(7):596–601.
  • Konstan MW, Butler SM, Wohl ME, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr. 2003;142(6):624–630.
  • Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc. 2001;101(4):438–442.
  • Sanders DB, Fink A, Mayer-Hamblett N, et al. Early life growth trajectories in cystic fibrosis are associated with pulmonary function at age 6 years. J Pediatr. 2015;167(5):1081–1088.e1.
  • Lai HJ, Shoff SM, Farrell PM, et al. Recovery of birth weight Z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis. Pediatrics. 2009;123(2):714–722.
  • Bor DH, Epstein PR. Pathogenesis of respiratory infection in the disadvantaged. Semin Respir Infect. 1991;6(4):194–203.
  • James WP, Nelson M, Ralph A, et al. Socioeconomic determinants of health. The contribution of nutrition to inequalities in health. BMJ. 1997;314(7093):1545–1549.
  • Giskes K, Avendano M, Brug J, et al. A systematic review of studies on socioeconomic inequalities in dietary intakes associated with weight gain and overweight/obesity conducted among European adults. Obes Rev. 2010;11(6):413–429.
  • Krolner R, Rasmussen M, Brug J, et al. Determinants of fruit and vegetable consumption among children and adolescents: a review of the literature. part II: qualitative studies. Int J Behav Nutr Phys Act. 2011;8:112.
  • Taylor-Robinson D, Whitehead M, Diggle P, et al. The effect of social deprivation on weight in the UK cystic fibrosis population. J Epidemiol Community Health. 2011;65:A389–A.
  • Pinto IC, Silva CP, Britto MC. Nutritional, clinical and socioeconomic profile of patients with cystic fibrosis treated at a referral center in Northeastern Brazil. J Bras Pneumol. 2009;35(2):137–143.
  • Anthony H, Paxton S, Bines J, et al. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis. J Psychosom Res. 1999;47(6):623–634.
  • Pearlin L. The sociological study of stress. J Health Soc Behav. 1989;30(3):241–256.
  • Turner RJ, Wheaton B, Lloyd DA. The epidemiology of social stress. Am Sociol Rev. 1995;60(1):104–125.
  • Thoits PA. Stress and health: major findings and policy implications. J Health Soc Behav. 2010;51(Suppl):S41–53.
  • Pearlin L, Schieman S, Fazio EM, et al. Stress, health, and the life course: some conceptual perspectives. J Health Soc Behav. 2005;46(2):205–219.
  • Evans GW, Kim P. Multiple risk exposure as a potential explanatory mechanism for the socioeconomic status-health gradient. Ann N Y Acad Sci. 2010;1186:174–189.
  • Thoits PA, Stress, coping, and social support processes: where are we? what next? J Health Soc Behav. 1995;35:53–79. Spec.
  • Marmot MG, Bosma H, Hemingway H, et al. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet. 1997;350(9073):235–239.
  • Harper S, Lynch J, Hsu WL, et al. Life course socioeconomic conditions and adult psychosocial functioning. Int J Epidemiol. 2002;31(2):395–403.
  • Berkman LF, Kawachi I. Social epidemiology. New York, NY: Oxford University Press;2000. p. 391. xxii.
  • Seeman TE, McEwen BS, Rowe JW, et al. Allostatic load as a marker of cumulative biological risk: macarthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;98(8):4770–4775.
  • McEwen BS, Seeman T. Protective and damaging effects of mediators of stress. elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad Sci. 1999;896:30–47.
  • Kubzansky LD, Kawachi I, Sparrow D. Socioeconomic status, hostility, and risk factor clustering in the normative aging study: any help from the concept of allostatic load?. Ann Behav Med. 1999;21(4):330–338.
  • Quittner AL, Schechter MS, Rasouliyan L, et al. Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States. Chest. 2010;137(3):642–650.
  • Oliver KN, Free ML, Bok C, et al. Stigma and optimism in adolescents and young adults with cystic fibrosis. J Cyst Fibros. 2014;13(6):737–744.
  • Patterson JM, Budd J, Goetz D, et al. Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics. 1993;91(2):383–389.
  • Everhart RS, Fiese BH, Smyth JM, et al. Family functioning and treatment adherence in children and adolescents with cystic fibrosis. Pediatr Allergy Immunol Pulmonol. 2014;27(2):82–86.
  • Cruz I, Marciel KK, Quittner AL, et al. Anxiety and depression in cystic fibrosis. Semin Respir Crit Care Med. 2009;30(5):569–578.
  • Iles N, Lowton K. What is the perceived nature of parental care and support for young people with cystic fibrosis as they enter adult health services? Health Soc Care Community. 2010;18(1):21–29.
  • Quittner AL, DiGirolamo AM, Michel M, et al. Parental response to cystic fibrosis: a contextual analysis of the diagnosis phase. J Pediatr Psychol. 1992;17(6):683–704.
  • Thompson RJ Jr., Gustafson KE, Hamlett KW, et al. Psychological adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment. J Pediatr Psychol. 1992;17(6):741–755.
  • Tluczek A, Laxova A, Grieve A, et al. Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults. J Cyst Fibros. 2014;13(2):227–234.
  • Besier T, Born A, Henrich G, et al. Anxiety, depression, and life satisfaction in parents caring for children with cystic fibrosis. Pediatr Pulmonol. 2011;46(7):672–682.
  • Schechter MS, Cruz I, Blackwell LS, et al. Risk factors for anxiety and depression in cystic fibrosis. Pediatr Pulmonol. 2010;Supple 33:109–110.
  • Besier T, Goldbeck L. Anxiety and depression in adolescents with CF and their caregivers. J Cyst Fibros. 2011;10(6):435–442.
  • Yohannes AM, Willgoss TG, Fatoye FA, et al. Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis. Respir Care. 2012;57(4):550–556.
  • Hilliard ME, Eakin MN, Borrelli B, et al. Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis. Health Psychol. 2015;34(5):496–504.
  • Beauchamp MH, Anderson V. Social: an integrative framework for the development of social skills. Psychol Bull. 2010;136(1):39–64.
  • Ernst MM, Johnson MC, Stark LJ. Developmental and psychosocial issues in cystic fibrosis. Pediatr Clin North Am. 2011;58(4):865–885, x.
  • Foster C, Eiser C, Oades P, et al. Treatment demands and differential treatment of patients with cystic fibrosis and their siblings: patient, parent and sibling accounts. Child Care Health Dev. 2001;27(4):349–364.
  • Barker DH, Driscoll KA, Modi AC, et al. Supporting cystic fibrosis disease management during adolescence: the role of family and friends. Child Care Health Dev. 2012;38(4):497–504.
  • Mc Hugh R, Mc Feeters D, Boyda D, et al. Coping styles in adults with cystic fibrosis: implications for emotional and social quality of life. Psychol Health Med. 2016;21(1):102–112.
  • Reynolds N, Mrug S, Britton L, et al. Spiritual coping predicts 5-year health outcomes in adolescents with cystic fibrosis. J Cyst Fibros. 2014;13(5):593–600.
  • Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci U S A. 2002;99(16):10929–10934.
  • Apter AJ, Reisine ST, Affleck G, et al. Adherence with twice-daily dosing of inhaled steroids. socioeconomic and health-belief differences. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1810–1817.
  • Rapoff MA, Belmont JM, Lindsley CB, et al. Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis. Arthritis Rheum-Arthritis Care Res. 2005;53(6):905–910.
  • Pendleton DA, David TJ. The compliance conundrum in cystic fibrosis. J R Soc Med. 2000;93(Suppl 38):9–13.
  • Schechter MS, McColley SA, Silva S, et al. Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr. 2009;155(5):634–4.
  • Schechter MS, McColley SA, Regelmann W, et al. Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis. J Pediatr. 2011;159(5):819–824 e1.
  • Ramos KJ, Quon BS, Psoter KJ, et al. Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States. J Cyst Fibros. 2016;15(2):196–203.
  • Quon BS, Psoter K, Mayer-Hamblett N, et al. Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respir Crit Care Med. 2012;186(10):1008–1013.
  • Merlo CA, Clark SC, Arnaoutakis GJ, et al. National healthcare delivery systems influence lung transplant outcomes for cystic fibrosis. Am J Transplant. 2015;15(7):1948–1957.
  • Stephenson A, Hux J, Tullis E, et al. Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario, Canada. Pediatr Pulmonol. 2011;46(4):376–384.
  • Taylor-Robinson D, Schechter MS. Health inequalities and cystic fibrosis. BMJ. 2011;343:d4818.
  • O’Connor GT, Quinton HB, Kahn R, et al. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol. 2002;33(2):99–105.
  • Watts KD, Seshadri R, Sullivan C, et al. Increased prevalence of risk factors for morbidity and mortality in the US hispanic CF population. Pediatr Pulmonol. 2009;44(6):594–601.
  • Buu MC, Sanders LM, Mayo J, et al. Assessing differences in mortality rates and risk factors between hispanic and non-hispanic patients with cystic fibrosis in California. Chest. 2016;149(2):380–389.
  • Dodge JA, Lewis PA, Stanton M, et al. Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J. 2007;29(3):522–526.
  • Schechter MS. Wealth as a disease modifier in cystic fibrosis. Lancet Respir Med. 2013;1(2):93–95.
  • Final report of the commission on social determinants of health. Geneva: Geneva, Switzerland World Health Organization; 2008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.